FBLG NASDAQ
FibroBiologics, Inc. Common Stock
1W: -3.6%
1M: -34.5%
3M: +39.9%
YTD: -81.0%
1Y: -88.9%
$0.93
-0.01 (-0.87%)
Weekly Expected Move ±10.0%
$1
$1
$1
$1
$1
Credit Risk of going bust: higher than 92% of companies Debt: 18.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.05 (down 95%), FibroBiologics, Inc. Common Stock would be worth roughly what it owes.
Total debt $1.5M against a stock market value of $6.3M.
Distance to default 1.22 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $664K (short-term plus half of long-term), stock volatility 139.3%; Altman Z'' -36.66. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $1.5M against a stock market value of $6.3M.
Distance to default 1.22 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $664K (short-term plus half of long-term), stock volatility 139.3%; Altman Z'' -36.66. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2024-09-24
Earliest Filing
2025-06-16
Latest Filing
investor: 4
acquirer: 1
supplier: 1
customer: 1
Counterparties (Filed by FBLG)
7 relationshipsCompanies named in FBLG's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| YA II PN, LTD. | — | investor | Holder of the Convertible Promissory Note and Investor under the Standby Equity Purchase Agreement. | 2025-06-16 | View |
| YA II PN, LTD. | — | investor | Holder of the Convertible Promissory Note and Investor under the Standby Equity Purchase Agreement. | 2024-12-31 | View |
| FibroBiologics, Inc. | FBLG | acquirer | Company issuing shares to GEM entities under a Side Letter agreement. | 2024-12-20 | View |
| GEM Global Yield LLC SCS | — | investor | Luxembourg entity purchasing shares and waiving commitment fees. | 2024-12-20 | View |
| GEM Yield Bahamas Limited | — | investor | Bahamas entity holding the warrant and purchasing shares. | 2024-12-20 | View |
| Charles River Laboratories, Inc. | CRL | supplier | Contract research and manufacturing organization providing services to Sponsor | 2024-09-24 | View |
| FibroBiologics, Inc. | FBLG | customer | Sponsor desiring services from Company | 2024-09-24 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-08 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-09-18 | Shareholder Vote; Regulation FD; Exhibits | View | |
| 2026-09-15 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-08-24 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-07-24 | Delisting Notice | View | |
| 2026-07-09 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-29 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-06-23 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-06 | Material Agreement; Exhibits | Agreement | View |
| 2026-05-05 | Officer/Director Change | View | |
| 2026-05-01 | Material Agreement; Exhibits | Agreement | View |
| 2026-04-20 | Regulation FD; Other Events; Exhibits | View | |
| 2026-04-17 | Bylaws Amendment; Exhibits | View | |
| 2026-04-09 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-04-09 | Material Agreement; Termination of Agreement; Other Events; Exhibits | Agreement | View |
| 2026-04-03 | Bylaws Amendment; Exhibits | View | |
| 2026-04-02 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-03-06 | Officer/Director Change | View | |
| 2026-02-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-02-06 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR